Geneuity (@Geneuity) header
Geneuity (@Geneuity) profile picture

Geneuity

@Geneuity

We improve medicine through innovative science. We integrate #genomics & #pathology to support #clinicaltrials, #companionDx & IVD #medicaldevice validation

 Maryville, TN
geneuity.com
Joined May 2015
  • Tweets452
  • Following231
  • Followers131
5Media
Photo by Geneuity (@Geneuity)Photo by Geneuity (@Geneuity)
Geneuity retweeted
MPLN (@molpathnet) profile picture
MPLN@molpathnet10 Jul 2017
Review @JCO_ASCO, Childhood Brain Tumors: Genome-Wide Discovery and Precision Medicine ascopubs.org/doi/pdf/10.1200…
1
Geneuity retweeted
MPLN (@molpathnet) profile picture
MPLN@molpathnet26 Jun 2017
B.Tandon MD. presents workshop: Contemporary Genomic studies in hematologic #pathology: #nextgenerationsequencing bit.ly/2s3CaW4
1
Geneuity retweeted
MPLN (@molpathnet) profile picture
MPLN@molpathnet26 Jun 2017
Dr. Bevan Tandon presents workshop: 13th Int.Conference on Pathology and Molecular Diagnosis June 27th in San Diego bit.ly/2symIVj
1
goo.gl/LTjEJS 'Tumor Agnostic' Cancer Drugs Seen Boosting Wider Genetic Tests
1
1
Geneuity retweeted
@gulleyj1 (@gulleyj1) profile picture
@gulleyj1@gulleyj12 Jun 2017
#ASCO17 One factor differentiating new PDL1 agents is ability to mediated ADCC. May be an important consideration for combination studies.
Image from @gulleyj1 (@gulleyj1)
4
64
11
66
NIH and FDA Release Protocol Template for Phase 2 and 3 IND/IDE Clinical Trials grants.nih.gov/grants/guide/…
1
Geneuity retweeted
MSP (@TweetsbyMSP) profile picture
MSP@TweetsbyMSP28 Apr 2017
MD of Alderley Park Dr Chris Doherty shares his thoughts on #InternationalCollaboration ahead of #BioTrinity2017 buff.ly/2oTjF62
3
Calr-mutant cells are attractive targets for new therapeutic strategies in #mpnsm by dr Araki @KomatsuNorioLab #MPNASIA17 @PharmaEssentia
Image from J.J. Kiladjian (@jjkiladjian)
10
1
12
Why doesn't #cancer immunotherapy work in every patient? A remarkable review of the topic cell.com/cell/fulltext/S0092… @CellPressNews #OA
Image from Eric Topol (@EricTopol)
Image from Eric Topol (@EricTopol)
Image from Eric Topol (@EricTopol)
Image from Eric Topol (@EricTopol)
3
264
7
278
What are Catapults? Learn more about the UK #innovation network in this @innovateuk blog ow.ly/V6cAX + catapult.org.uk
Image from Catapult Network (@Catapult_UK)
8
2
9
It's not the antibody its the ........Quantitative Comparison of Antibodies to PD-L1 ow.ly/Obyq308ZIWX
2
1
Longitudinal analysis of treatment-induced #genomic alterations in #glioma bit.ly/2k0akH2
Image from Genome Medicine (@GenomeMedicine)
5
4
US "Cures Act": Free @fdalawblog webinars in January; pharma/bio, device & combo products fdalawblog.net/fda_law_blog_… #medicine #bioethics
2
#IDH1 & 2 mutations in #Glioma - the latest #biomarkers factsheet on #OncologyPRO ow.ly/LD1A306I2zh
Image from ESMO - Eur. Oncology (@myESMO)
13
2
7
It's good to have hope for precision oncology. But, we must remain critical, demand evidence, and temper disproportionate enthusiasm. nitter.gq/n8pennell/status/80143…
Nathan A. Pennell MD, PhD, FASCO (@n8pennell) profile pictureNathan A. Pennell MD, PhD, FASCO
@n8pennell23 Nov 2016
ERCC1 as a cautionary tale for biomarker development in cancer. Not as straightforward as it seems #LCSM theoncologist.alphamedpress.…
2
2
3
Geneuity retweeted
MPLN (@molpathnet) profile picture
MPLN@molpathnet9 Nov 2016
Meet MPLN's Dr. Bevan Tandon at #AMP2016 Poster H50. #nextgenerationsequencing #IgVH somatic hypermutation #CLL bit.ly/2e64boU
1
Geneuity retweeted
MPLN (@molpathnet) profile picture
MPLN@molpathnet1 Nov 2016
MPLN now offers #IgVH SHM status by NGS. bit.ly/2e64boU. A primary component of the CLL-IPI @TheLancet bit.ly/2efD1Q5 nitter.gq/ASHClinicalNews/status…
ASH Clinical News (@ASHClinicalNews) profile pictureASH Clinical News@ASHClinicalNews15 Jul 2016
CLL-IPI: A new International Staging System for chronic lymphocytic leukemia #CLL ow.ly/Jm5f302bDTU
1
FDA Seeks Input On Emerging Sciences And Technologies ow.ly/5xJ4305tepw
1
Geneuity retweeted
JAMA (@JAMA_current) profile picture
JAMA
@JAMA_current23 Oct 2016
Sequencing Technologies for Understanding Hereditary Ataxias ja.ma/2ejFfya
Image from JAMA (@JAMA_current)
7
13
Geneuity retweeted
MPLN (@molpathnet) profile picture
MPLN@molpathnet24 Oct 2016
MPLN an Archer certified provider; CLIA and @Geneuity clinical trials developing #nextgenerationsequencing solid and liquid tumor panels nitter.gq/archerdxinc/status/790…
ArcherDX, Inc. (@archerdxinc) profile pictureArcherDX, Inc.@archerdxinc24 Oct 2016
Archer presents @CDxSymp2016 => Development of an NGS-Based Clinical Trial Assay for Entrectinib, a Potent TKI => bit.ly/2dvPOA9
Image from ArcherDX, Inc. (@archerdxinc)
1
Load more